Dutasteride is an advanced, high-potency dual (Type I and Type II) 5-alpha reductase enzyme inhibitor designed for maximum androgen suppression. Unlike finasteride, which selectively blocks only the Type II isoenzyme, dutasteride inhibits both Type I and Type II forms responsible for converting testosterone into dihydrotestosterone (DHT). This comprehensive dual blockade achieves a rapid, near-complete (over 90%) decrease in serum DHT levels. This intensive hormonal regulation aggressively halts progressive prostate gland growth, significantly lowers the long-term risk of acute urinary retention, and keeps the lower urinary tract pathways structurally protected against androgen-mediated tissue overgrowth.